SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-060496
Filing Date
2024-07-10
Accepted
2024-07-10 16:09:58
Documents
2
Period of Report
2024-07-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1588
2 POWER OF ATTORNEY ea020910802ex-24_virpax.htm EX-24 5857
  Complete submission text file 0001213900-24-060496.txt   8984
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1055 WESTLAKES DRIVE SUITE 300 BERWYN PA 19312
Business Address
Field Katharyn (Reporting) CIK: 0002029888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 241110047